http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107912056-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J17-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5079 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J5-0015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2015-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107912056-B |
| titleOfInvention | Method for screening the regulator of chondriokinesis |
| abstract | The present invention relates to: use the method for the cell screening chondriokinesis controlling agent handled with protopanoxadiol (PPD) type ginsenoside compound；The composition for being used to screen chondriokinesis controlling agent containing PPD type ginsenoside compound；And the kit comprising the composition.By using the method for screening chondriokinesis regulator according to the present invention, the preparation that can effectively find prevention by control chondriokinesis, improve or treat mitochondria related disease.Therefore this method can be widely applied for the therapeutic agent of exploitation mitochondria related disease. |
| priorityDate | 2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.